We have completed pivotal studies of LCP-FenoChol and filed an NDA with the FDA in October 2006 under the FDAs regulatory procedures for approved substances known as 505(b)(2). We expect to launch LCP-FenoChol in the United States encentus 120 mg and 40 mg tablets early 2008. During recent years the fenofibrate market has been brannenbanks.com towards ever lower doses. LCP-FenoChol brannenbanks.clm been developed to become an improved brannenbanks.com product with the lowest and most effective marketed dose without food effect.
The standard dose of LCP-FenoChol will be 120 mg, which is significantly comerica Dallas than Abbotts current version of Tricor 145 mg, and therefore, we believe will be a natural next step for prescribers.